Journal of clinical neurology

Korean Neurological Association (대한신경과학회)
권호 표지
DOI QR코드

DOI QR Code

Current Status of the Diagnosis and Management of Amyotrophic Lateral Sclerosis in Korea: A Multi-Center Cross-Sectional Study

  • Bae, Jong Seok (Department of Neurology, Inje University College of Medicine) ;
  • Hong, Yoon-Ho (Department of Neurology, Seoul National University College of Medicine) ;
  • Baek, WonKi (Department of Neurology, Hanyang University College of Medicine) ;
  • Sohn, Eun Hee (Department of Neurology, Chungnam National University College of Medicine) ;
  • Cho, Joong-Yang (Department of Neurology, Inje University College of Medicine) ;
  • Kim, Byung-Jo (Department of Neurology, Korea University College of Medicine) ;
  • Kim, Seung Hyun (Department of Neurology, Hanyang University College of Medicine) ;
  • The Korean ALS/MND Research Group, The Korean ALS/MND Research Group (The Korean ALS/MND Research Group)
  • Published : 2012.12.31
⟨ Previous Next ⟩

Abstract

Background and Purpose Recently published, evidence-based guidelines should alter the management of amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). However, the newest recommendations for ALS/MND therapy are not reflected in actual clinical practice. We sought to evaluate the current status of the diagnosis and management of ALS in Korea. Methods The Korean ALS/MND research group was organized in 2010, involving more than 50 neurologists from neuromuscular centers in Korea. Participating centers collected data from April to September 2010 on the diagnosis and management of patients with ALS. Data forms from the ALS patient care database, which is a component of the ALS clinical assessment, research, and education program (http://www.outcomes-umassmed.org/ALS/), were modified and used for data collection. Results In total, 373 sporadic ALS cases from 35 centers were enrolled. The demographic features and clinical findings were similar to those in previous reports from other countries. The mean age at onset was 50-60 years, and a slight male predominance was observed. The enrolled patients predominantly showed focal onset of cervical or lumbosacral symptoms. Only about onehalf of the indicated patients (31.4%) received a physician's recommendation for a parenteral gastrostomy, and 18.1% underwent the procedure. Noninvasive ventilation was recommended in 23% of patients, but applied in only 9.5% of them. Tracheostomy was performed in 12.7% of patients. Conclusions The demographic and clinical features of the diagnosis and management of ALS in Korea are similar to those reported in other countries; however, supportive management, as recommended in evidence-based guidelines, are not yet widely recommended or performed for patients with ALS in Korea.

Keywords

References

  1. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942-955. https://doi.org/10.1016/S0140-6736(10)61156-7
  2. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1227-1233. https://doi.org/10.1212/WNL.0b013e3181bc01a4
  3. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73: 1218-1226. https://doi.org/10.1212/WNL.0b013e3181bc0141
  4. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999;52:1311-1323. https://doi.org/10.1212/WNL.52.7.1311
  5. Lechtzin N, Wiener CM, Clawson L, Davidson MC, Anderson F, Gowda N, et al. Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:9-15. https://doi.org/10.1080/14660820310017335
  6. Mitsumoto H, Davidson M, Moore D, Gad N, Brandis M, Ringel S, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:177-185. https://doi.org/10.1080/14660820310011728
  7. Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, Ringel SP, et al. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol 2009;65 Suppl 1:S24-S28. https://doi.org/10.1002/ana.21556
  8. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008;79:6-11. https://doi.org/10.1136/jnnp.2006.104828
  9. Bradley WG, Anderson F, Bromberg M, Gutmann L, Harati Y, Ross M, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology 2001;57:500-504. https://doi.org/10.1212/WNL.57.3.500
  10. Miller RG, Anderson FA Jr, Bradley WG, Brooks BR, Mitsumoto H, Munsat TL, et al. The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology 2000;54:53-57. https://doi.org/10.1212/WNL.54.1.53
  11. Baek W, Park A, Kim HY, Kim SH. Amyotrophic lateral sclerosis in Korea: clinical characteristics and prognostic factors. J Korean Neurol Assoc 2011;29:16-24.
  12. Bae JS. A proposal for the establishment of an Korean ALS database. J Korean Neurol Assoc 2008;26 Suppl 3:S106-S107.
  13. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124 Suppl:96-107.
  14. Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research. J Neurol Sci 1999;169: 2-12. https://doi.org/10.1016/S0022-510X(99)00209-9
  15. Beghi E. 127th ENMC International Workshop: implementation of a European registry of ALS. Naarden, The Netherlands, 8-10 October 2004. Neuromuscul Disord 2006;16:46-53.
  16. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-719. https://doi.org/10.1093/brain/118.3.707
  17. Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci 2001;191:3-9. https://doi.org/10.1016/S0022-510X(01)00630-X
  18. de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004;63:1240-1244. https://doi.org/10.1212/01.WNL.0000140706.52798.BE
  19. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53:1059-1063. https://doi.org/10.1212/WNL.53.5.1059
  20. Lopes J, Russell DM, Whitwell J, Jeejeebhoy KN. Skeletal muscle function in malnutrition. Am J Clin Nutr 1982;36:602-610. https://doi.org/10.1093/ajcn/36.4.602
  21. Murciano D, Rigaud D, Pingleton S, Armengaud MH, Melchior JC, Aubier M. Diaphragmatic function in severely malnourished patients with anorexia nervosa. Effects of renutrition. Am J Respir Crit Care Med 1994;150:1569-1574. https://doi.org/10.1164/ajrccm.150.6.7952616
  22. Rigaud D, Moukaddem M, Cohen B, Malon D, Reveillard V, Mignon M. Refeeding improves muscle performance without normalization of muscle mass and oxygen consumption in anorexia nervosa patients. Am J Clin Nutr 1997;65:1845-1851. https://doi.org/10.1093/ajcn/65.6.1845
  23. Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff MM, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005;65:1264-1267. https://doi.org/10.1212/01.wnl.0000180717.29273.12
  24. Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997;127:450-453. https://doi.org/10.7326/0003-4819-127-6-199709150-00006
  25. Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999;164:82-88. https://doi.org/10.1016/S0022-510X(99)00045-3
  26. Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luís ML. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ ALS patients: survival rates in a controlled trial. J Neurol Sci 1995;129 Suppl:19-26. https://doi.org/10.1016/0022-510X(95)00052-4
  27. Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 2001;24: 403-409. https://doi.org/10.1002/1097-4598(200103)24:3<403::AID-MUS1013>3.0.CO;2-3
  28. Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003;61:171-177. https://doi.org/10.1212/01.WNL.0000076182.13137.38
  29. Lyall RA, Donaldson N, Fleming T, Wood C, Newsom-Davis I, Polkey MI, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001;57:153-156. https://doi.org/10.1212/WNL.57.1.153
  30. Moss AH, Casey P, Stocking CB, Roos RP, Brooks BR, Siegler M. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology 1993;43: 438-443. https://doi.org/10.1212/WNL.43.2.438
  31. Moss AH, Oppenheimer EA, Casey P, Cazzolli PA, Roos RP, Stocking CB, et al. Patients with amyotrophic lateral sclerosis receiving longterm mechanical ventilation. Advance care planning and outcomes. Chest 1996;110:249-255. https://doi.org/10.1378/chest.110.1.249
  32. Hayashi H, Oppenheimer EA. ALS patients on TPPV: totally lockedin state, neurologic findings and ethical implications. Neurology 2003; 61:135-137. https://doi.org/10.1212/01.WNL.0000069925.02052.1F
  33. Shon EH, Kim BJ, Kim JK, Bae JS, Baek W, Suh BC, et al. Establishment and perspective of the Korean ALS registry. J Korean Soc Clin Neurophysiol 2011;13:71-79.

Cited by

  1. Spectrum of Cognitive Impairment in Korean ALS Patients without Known Genetic Mutations vol.9, pp.2, 2012, https://doi.org/10.1371/journal.pone.0087163
  2. 근위축성측삭경화증 환자를 돌보는 가족의 우울과 간병 부담감 vol.45, pp.2, 2012, https://doi.org/10.4040/jkan.2015.45.2.202
  3. Socioeconomic costs of amyotrophic lateral sclerosis according to staging system vol.16, pp.3, 2012, https://doi.org/10.3109/21678421.2014.999791
  4. Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis vol.11, pp.4, 2012, https://doi.org/10.3988/jcn.2015.11.4.376
  5. Tracheostomy and invasive mechanical ventilation in amyotrophic lateral sclerosis: decision-making factors and survival analysis vol.56, pp.4, 2012, https://doi.org/10.5692/clinicalneurol.cn-000837
  6. A case report on the use of processed Glycyrrhiza uralensis extract and Korean medical treatment for a patient with Amyotrophic Lateral Sclerosis(ALS) vol.33, pp.2, 2012, https://doi.org/10.13045/acupunct.2016029
  7. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia vol.87, pp.8, 2012, https://doi.org/10.1136/jnnp-2015-312751
  8. Home mechanical ventilation for patients with Amyotrophic Lateral Sclerosis: A Canadian Thoracic Society clinical practice guideline vol.3, pp.1, 2019, https://doi.org/10.1080/24745332.2018.1559644
  9. Epidemiology of ALS in Korea using nationwide big data vol.90, pp.4, 2012, https://doi.org/10.1136/jnnp-2018-318974
  10. Ethical and legal issues of tracheostomy ventilation in patients with amyotrophic lateral sclerosis vol.28, pp.3, 2012, https://doi.org/10.1177/2010105819828753
  11. Retrospective longitudinal study of ALS in Cyprus: Clinical characteristics, management and survival vol.14, pp.9, 2019, https://doi.org/10.1371/journal.pone.0220246
  12. Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study vol.91, pp.5, 2012, https://doi.org/10.1136/jnnp-2019-322317
  13. Natural history and clinical features of ALS in Malaysia vol.22, pp.1, 2012, https://doi.org/10.1080/21678421.2020.1832121
  14. A survey on patients' disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in Malaysia vol.11, pp.4, 2021, https://doi.org/10.2217/nmt-2021-0004